HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-04
DOI
10.3389/fmed.2021.713981
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice
- (2020) Michael Bobardt et al. PLoS One
- The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
- (2020) Janne Tegder Martinsen et al. Frontiers in Immunology
- Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults with HIV-1
- (2020) Sharon A Riddler et al. CLINICAL INFECTIOUS DISEASES
- Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients
- (2020) Shiori Yoshikawa et al. JOURNAL OF INFECTIOUS DISEASES
- Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection
- (2020) Kasha P. Singh et al. PLoS Pathogens
- Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?
- (2020) Andre J Jeyarajan et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
- (2019) Murali Ganesan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease
- (2019) David L. Wyles Clinics in Liver Disease
- The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice
- (2019) Philippe Gallay et al. PLoS One
- The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
- (2019) Günther Schönrich et al. Frontiers in Cellular and Infection Microbiology
- Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
- (2019) Thomas S. Uldrick et al. JAMA Oncology
- Immunotherapy for cancer in people living with HIV
- (2019) Jean-Philippe Spano et al. AIDS
- A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
- (2019) Joseph Kuo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Immunological Efficacy of Tenofovir Disproxil Fumarate-Containing Regimens in Patients With HIV-HBV Coinfection: A Systematic Review and Meta-Analysis
- (2019) Taiyi Jiang et al. Frontiers in Pharmacology
- Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
- (2019) Jia-Juen Lin et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
- (2019) Xuanye Zhang et al. Journal for ImmunoTherapy of Cancer
- Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
- (2019) Oscar Blanch-Lombarte et al. Journal of Clinical Medicine
- Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection
- (2019) Lesley J. Scott DRUGS
- Prevalence and burden of HBV co‐infection among people living with HIV: A global systematic review and meta‐analysis
- (2019) Lucy Platt et al. JOURNAL OF VIRAL HEPATITIS
- Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV
- (2019) Robert C Bollinger et al. Lancet HIV
- Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
- (2018) Vanessa A. Evans et al. AIDS
- TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
- (2018) Carolina Boni et al. GASTROENTEROLOGY
- Twenty-Five Years of Lamivudine
- (2018) Romina Quercia et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
- (2018) Harry L.A. Janssen et al. JOURNAL OF HEPATOLOGY
- Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells
- (2018) Li Li et al. JOURNAL OF HEPATOLOGY
- Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism
- (2018) Congrong Niu et al. JOURNAL OF HEPATOLOGY
- Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
- (2018) Kosh Agarwal et al. JOURNAL OF VIRAL HEPATITIS
- ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
- (2018) Darren Wong et al. LIVER INTERNATIONAL
- Safety and efficacy of anti-PD-1 therapy for metastatic melanoma and non-small-cell lung cancer in patients with viral hepatitis
- (2018) Anita Kothapalli et al. MELANOMA RESEARCH
- When Hepatitis B Virus Meets Interferons
- (2018) Guangyun Tan et al. Frontiers in Microbiology
- Hepatitis B virus infection
- (2018) Man-Fung Yuen et al. Nature Reviews Disease Primers
- Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion
- (2018) Michael W. Rowley et al. Annals of Hepatology
- Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
- (2017) Angela Tsai et al. JOURNAL OF VIROLOGY
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
- (2017) Joel Gallant et al. LANCET
- Evolving epidemiology of HIV-associated malignancies
- (2017) Meredith S. Shiels et al. Current Opinion in HIV and AIDS
- Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study
- (2017) Pedro Cahn et al. Journal of the International AIDS Society
- Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections
- (2017) Sanghyun Lee et al. Frontiers in Immunology
- In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B
- (2017) Daniel Trepanier et al. Pharmaceutics
- TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells
- (2016) Rujuta A. Bam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras
- (2016) Marina B. Klein et al. CLINICAL INFECTIOUS DISEASES
- Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA
- (2016) Yijia Li et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells
- (2016) Rasmus Offersen et al. JOURNAL OF VIROLOGY
- Safety of immune checkpoint inhibitors in Chinese patients with melanoma
- (2016) Xizhi Wen et al. MELANOMA RESEARCH
- PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
- (2016) Riddhima Banga et al. NATURE MEDICINE
- Pembrolizumab (Keytruda)
- (2016) Gerry Kwok et al. Human Vaccines & Immunotherapeutics
- Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials
- (2015) François Raffi et al. AIDS
- Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)
- (2015) David J. Templeton et al. BMC INFECTIOUS DISEASES
- Pre-Exposure Prophylaxis to Prevent HIV Infection: Current Status, Future Opportunities and Challenges
- (2015) Douglas S. Krakower et al. DRUGS
- The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
- (2015) Seiichi Sato et al. IMMUNITY
- Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B
- (2015) Bei Xu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
- (2015) Stephan Menne et al. JOURNAL OF HEPATOLOGY
- SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver Damage
- (2015) Tristan I. Evans et al. JOURNAL OF INFECTIOUS DISEASES
- Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
- (2015) Lijun Gu et al. PLoS One
- Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
- (2015) Vijayakumar Velu et al. Retrovirology
- HIV infection
- (2015) Steven G. Deeks et al. Nature Reviews Disease Primers
- The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action
- (2015) Philippe A. Gallay et al. PLoS One
- Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009
- (2014) Mira Hleyhel AIDS
- Effect of Antiretroviral HIV Therapy on Hepatitis B Virus Replication and Pathogenicity
- (2014) Lutz G. Gürtler INTERVIROLOGY
- CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
- (2014) Xiang Zhang et al. JOURNAL OF HEPATOLOGY
- Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy
- (2014) Megan Crane et al. JOURNAL OF INFECTIOUS DISEASES
- Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
- (2014) A. Shlomai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis B and human immunodeficiency virus co-infection
- (2014) Bao-Chau Phung WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review
- (2014) Hsin-Yun Sun WORLD JOURNAL OF GASTROENTEROLOGY
- Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance
- (2014) Luis Menéndez-Arias et al. Current Opinion in Virology
- Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States
- (2013) Hilary A. Robbins et al. AIDS
- GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
- (2013) Robert E. Lanford et al. GASTROENTEROLOGY
- CXC chemokine IP-10: a key actor in liver disease?
- (2013) Lin-Jiao Chen et al. Hepatology International
- British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013
- (2013) et al. HIV MEDICINE
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis
- (2013) Paul A. Roethle et al. JOURNAL OF MEDICINAL CHEMISTRY
- PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication
- (2013) X. F. Wang et al. JOURNAL OF VIRAL HEPATITIS
- Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
- (2013) Nicole A de Weerd et al. NATURE IMMUNOLOGY
- Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
- (2013) Huw Price et al. PLoS One
- Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial
- (2013) Prudence Ive et al. PLoS One
- Comparative Efficacy of Lamivudine and Emtricitabine: A Systematic Review and Meta-Analysis of Randomized Trials
- (2013) Nathan Ford et al. PLoS One
- Innate immune detection of microbial nucleic acids
- (2013) Claudia Gürtler et al. TRENDS IN MICROBIOLOGY
- Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol
- (2012) Su-Yang Liu et al. IMMUNITY
- Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
- (2012) Mika Kurokawa et al. JOURNAL OF GASTROENTEROLOGY
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study
- (2012) Tetsuya Hosaka et al. JOURNAL OF GASTROENTEROLOGY
- Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients
- (2012) L. Kosi et al. JOURNAL OF VIRAL HEPATITIS
- HIV–HBV Coinfection — A Global Challenge
- (2012) Athena P. Kourtis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclophilin A Restricts Influenza A Virus Replication through Degradation of the M1 Protein
- (2012) Xiaoling Liu et al. PLoS One
- A Multicentre Molecular Analysis of Hepatitis B and Blood-Borne Virus Coinfections in Viet Nam
- (2012) Linda Dunford et al. PLoS One
- Hepatitis B Virus Infection in Human Immunodeficiency Virus Infected Southern African Adults: Occult or Overt – That Is the Question
- (2012) Trevor G. Bell et al. PLoS One
- Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
- (2012) Anchalee Avihingsanon et al. AIDS Research and Therapy
- New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B
- (2011) Vincent Soriano et al. AIDS
- Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine
- (2011) Haruhiko Kobashi et al. HEPATOLOGY RESEARCH
- Hepatitis B Virus Induces a Novel Inflammation Network Involving Three Inflammatory Factors, IL-29, IL-8, and Cyclooxygenase-2
- (2011) Y. Yu et al. JOURNAL OF IMMUNOLOGY
- Increasing burden of liver disease in patients with HIV infection
- (2011) Deepak Joshi et al. LANCET
- Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression
- (2010) David M Iser et al. AIDS
- Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV–HBV coinfection in Thailand
- (2010) Anchalee Avihingsanon et al. ANTIVIRAL THERAPY
- Epidemiology of Hepatitis B Virus Infection in a US Cohort of HIV‐Infected Individuals during the Past 20 Years
- (2010) Helen M. Chun et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
- (2010) Ryan D. Cooper et al. CLINICAL INFECTIOUS DISEASES
- Treatment of HBV/HCV coinfection
- (2010) Andrej Potthoff et al. EXPERT OPINION ON PHARMACOTHERAPY
- Management of HIV and hepatitis virus coinfection
- (2010) MariaCássia Mendes-Corrêa et al. EXPERT OPINION ON PHARMACOTHERAPY
- HIV protein gp120 and chemokines receptor for liver fibrosis
- (2010) G. Svegliati-Baroni et al. GUT
- Hepatitis B and human immunodeficiency virus coinfection
- (2010) Chloe L. Thio HEPATOLOGY
- Hepatitis B Virus (HBV) Surface Antigen Interacts with and Promotes Cyclophilin A Secretion: Possible Link to Pathogenesis of HBV Infection
- (2010) X. Tian et al. JOURNAL OF VIROLOGY
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
- (2010) A. P. Venook et al. ONCOLOGIST
- Development of fatal acute liver failure in HIV-HBV coinfected patients
- (2010) Albert M Anderson WORLD JOURNAL OF GASTROENTEROLOGY
- Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection
- (2009) Reto Nüesch et al. AIDS
- Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel
- (2009) Vincent Soriano et al. AIDS
- Viral hepatitis and HIV co-infection
- (2009) Vincent Soriano et al. ANTIVIRAL RESEARCH
- Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication
- (2009) Xiaoling Liu et al. CELLULAR MICROBIOLOGY
- Impact of Hepatitis B Virus Infection on Human Immunodeficiency Virus Response to Antiretroviral Therapy in Nigeria
- (2009) John Idoko et al. CLINICAL INFECTIOUS DISEASES
- Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
- (2009) Caroline Bazzoli et al. CLINICAL PHARMACOKINETICS
- gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis
- (2009) R. Bruno et al. GUT
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study
- (2009) Dominique Salmon-Ceron et al. JOURNAL OF HEPATOLOGY
- HIV Induces TRAIL Sensitivity in Hepatocytes
- (2009) Challagundla K. Babu et al. PLoS One
- Immune Reconstitution Inflammatory Syndrome: A Reappraisal
- (2008) Martyn A. French CLINICAL INFECTIOUS DISEASES
- Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C
- (2008) Ashwin Balagopal et al. GASTROENTEROLOGY
- The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound
- (2008) Nadia Warner et al. HEPATOLOGY
- Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase
- (2008) Egor P. Tchesnokov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis B viruses: Reverse transcription a different way
- (2008) Michael Nassal VIRUS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now